editedbook
Publication: IIP Proceedings Year: 2022, Month: November Page No: 179-188, ISSN/ISBN: 978-93-95632-88-1, DOI/Link: https://rsquarel.org/assets/docupload/rsl2023C7EAAC6C8E2167A.pdf
BIO-MARKERS
Area/Stream: Biotechnology, Authors: Naga Jogayya Kothakota, Suryakanta Swain, Bikash Ranjan Jena Keywords: Biomarkers, Clinical studies, Species Identification, Pathogen identification, Pharmacodynamics Book Name /series: Futuristic Trends in Biotechnology, Volume 2, Book 27, Part 2, Chapter 2Publication: IIP Proceedings Year: 2022, Month: November Page No: 179-188, ISSN/ISBN: 978-93-95632-88-1, DOI/Link: https://rsquarel.org/assets/docupload/rsl2023C7EAAC6C8E2167A.pdf
Abstract:
Biomarkers offer an innovative and effective method to explore the scope of different applications, such as sickness diagnosis. and various research studies requests in experimental and investigative epidemiology, rigorous medical studies, monitoring, assessment, and prediction. These markers, defined as changes in the constituents of tissues or bodily liquids, allow for homogeneous arrangement of a sickness and risk aspects. They can help us understand disease pathogenicity. Biomarkers are also representing the whole disease spectrum, from early to late stages. The primary applications of biomarkers in clinical research are described in this concise overview. The validity of biomarkers must be carefully assessed concerning the disease stage. Variability in biomarker measurements varies due to factors ranging from the individual to the laboratory. In this review, Biomarker analysis issues are critically discussed, as these are systematic recommendations for dealing with bias and confounding.
Cite this: Naga Jogayya Kothakota, Suryakanta Swain, Bikash Ranjan Jena,"BIO-MARKERS", Futuristic Trends in Biotechnology, Volume 2, Book 27, Part 2, Chapter 2, November, 2022, 179-188, 978-93-95632-88-1, https://rsquarel.org/assets/docupload/rsl2023C7EAAC6C8E2167A.pdf
Views: 4180
Download File
News
